期刊文献+

曲美他嗪对慢性肾衰竭大鼠左心室重塑及血浆脑钠素的影响 被引量:3

Effects of trimetazidine on left ventricular remodeling and plasma brain natriuretic peptide level in rats with chronic renal failure
下载PDF
导出
摘要 目的观察曲美他嗪对慢性肾衰竭大鼠左心室重塑的影响及血浆脑钠素(BNP)的变化。方法 SD大鼠随机分为假手术组、手术对照组及曲美他嗪小、中、大剂量(3、6、9 mg/kg)治疗组,每组10只;后4组大鼠建立5/6肾切除术慢性肾衰竭模型,后3组大鼠每日灌胃给药,手术对照组则给予等量生理盐水,持续17周。实验结束时,对大鼠心脏进行超声检查,监测收缩压、舒张压、平均动脉压及心率,测定血浆BNP,并取心脏组织进行病理形态学观察。结果心超检查结果表明:曲美他嗪中、大剂量组大鼠左室收缩末内径、左室舒张末期前壁厚度、左室收缩末期前壁厚度、左室舒张末期后壁厚度均低于手术对照组(P<0.05)。假手术组收缩压、舒张压及平均动脉压、血浆BNP水平均低于其余4组(P<0.01,P<0.05);曲美他嗪中、大剂量治疗组BNP均低于手术对照组(P<0.05)。光镜下可见手术对照组心肌细胞排列紊乱、肥大,部分心肌纤维化;电镜下手术对照组可见大片心肌纤维溶解,线粒体增多、肿胀、空泡化;曲美他嗪治疗组心肌损伤均较手术对照组改善,且随曲美他嗪剂量增大有进一步好转趋势。结论曲美他嗪降低血浆BNP水平,可改善慢性肾衰竭大鼠左心室重塑。 Objective To observe the effects of trimetazidine(TMZ) on left ventricular remodeling and plasma brain natriuretic peptide(BNP) level in rats with chronic renal failure(CRF).Methods Male Sprague-dawley(SD) rats were randomly divided into sham group,CRF group,small-(3 mg/kg),medium-(6 mg/kg),and high-TMZ(9 mg/kg) treatment groups,with each group containing 10 rats.Animals in the latter four groups received 5/6 subtotal nephrectomies.TMZ was intragastrically administered to rats for 17 weeks in three TMZ groups,while normal saline was given to rats in CRF group.At the end of the study,transthoracic echocardiography was performed,the systolic blood pressure(SBP),diastolic blood pressure(DBP),mean arterial pressure(MBP),and BNP were measured,and the cardiac tissues were obtained for pathological examination.Results Echocardiography showed that the left ventricle end-systolic dimensions,anterior wall end-diastolic and end-systolic thicknesses,and posterior wall end-diastolic thickness in the medium-and high-TMZ groups were significantly decreased compared with those in the sham control group(P〈0.05).Compared with the sham control group,the rest four groups had significantly higher systolic/diastolic blood pressure,mean arterial pressure and BNP level (P〈0.01,P〈0.05).The BNP levels in medium-and high-TMZ groups were significantly lower than that in the sham control group(P〈0.05).Irregular arrangement and hypertrophy of the cardiomyocytes and myocardial fibrosis were observed in the control group under light microscope,and mitochondrial swelling,vacuolation and focal muscle fiber dissolution were observed under electron microscope.The pathological changes were improved by TMZ treatment in a dose-dependent manner.Conclusion TMZ may improve left ventricular remodeling and decrease BNP level in CRF rats.
出处 《第二军医大学学报》 CAS CSCD 北大核心 2011年第3期266-270,共5页 Academic Journal of Second Military Medical University
基金 上海市卫生局科研基金(2009255)~~
关键词 慢性肾功能衰竭 曲美他嗪 心室重构 脑钠素 chronic kidney failure; trimetazidine; ventricular remodeling; brain natriuretic peptide;
  • 相关文献

参考文献13

  • 1Cowie M R, Mendez G F. BNP and congestive heart failure[J]. Prog Cardiovasc Dis, 2002,44 : 293-321.
  • 2刘梅颜.2008 BNP中西方专家共识高峰论坛会议纪要[J].中国医药导刊,2008,10(6):928-930. 被引量:20
  • 3Cataliotti A, Malatino L S, Jougasaki M, Zoccali C, Castellino P,Giacone G, et al. Circulating natriuretic peptide concentra- tions in patients with end-stage renal disease: role of brain na triuretic peptide as a biomarker for ventricular remodeling[J]. Mayo Clin Proc,2001,76:1111-1119.
  • 4周文彦,倪兆慧,方炜,顾乐怡,王琴,牟姗,曹励欧,俞赞喆,钱家麒.慢性肾脏病非透析患者脑钠素与动脉粥样硬化及心功能的关系[J].中华肾脏病杂志,2007,23(3):162-166. 被引量:21
  • 5Banach M, Rysz J, Goch A, Mikhailidis D P, Rosano G M. The role of trimetazicline after acute myocardial in~aretion[J]. Curr Vasc Pharmacol, 2008,6 : 282-291.
  • 6Marazzi G, Gebara O, Vitale C, Caminiti G, Wajngarten M, Volterrani M,et al. Effect of trimetazidine on quality of life in eld erly patients with isehemic dilated eardiomyopathy[J]. Adv Ther,2009,26:455 461.
  • 7Mall G, Huther W, Schneider J, Lundin P,Ritz E. Diffuse inter myocardiocytic fibrosis in uraemic patients[J]. Nephrol Dial Transplant, 1990,5 : 39-44.
  • 8Pilz S, Scharnagl H, Titan B, Seelhorst U, Wellnitz B, Boehm B O,et al. Free fatty acids are independently associated with all cause and cardiovascular mortality in subjects with coronary artery disease[J]. J Ciin Endocrinol Metab, 2006,91 : 2542-2547.
  • 9李洪涛,黄高忠,殷仁富.心脏脂肪酸代谢[M].//殷仁富,陈金明.心脏能量学——代谢与治疗.上海:第二军医大学出版社,2002:5i-72.
  • 10Tselepis A, Doulias P, Lourida E, Glantzounis G, Tsimoyiannis E, Galaris D. Trimetazidine protects low density lipoproteins from oxidation and cultured cells exposed to H202 from DNA damage[J]. Free Radic Biol Med, 2001,30 : 1357-1364.

二级参考文献17

  • 1金烈,韦铁民,曾春来.血液透析前后血浆B型钠尿肽的变化及对心力衰竭的诊断价值[J].中华肾脏病杂志,2005,21(3):160-160. 被引量:4
  • 2Akiba T, Tachib ana K, Togashi K, et al. Plasma human brain natriuretic peptide in chronic renal failure. Clin Nephrol, 1995, 44 Suppl 1:S61-S64.
  • 3Safley DM, Awad A, Sullivan RA, et al. Changes in B-type natriuretic peptide levels in hemodialysis and the effect of depressed left ventricular function. Adv Chronic Kidney Dis,2005, 12:117-124.
  • 4Foley RN, Parfrey PS, Samak MJ. Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis, 1998, 32 (5 Suppl 3):Sl12-Sl19.
  • 5Levin A, Djurdjev O,Barrett B, et al. Cardiovascular disease in patients with chronic kidney disease:geting to the heart of the matter. Am J Kidney Dis, 2001, 38:1398-1407.
  • 6Mallamaci F, Zoccali C, Tripepi G, et al. Diagnostic potential of cardiac natriuretic peptides in dialysis patients. Kidney Int, 2001, 59:1559-1566.
  • 7Cataliotti A, Malatino LS, Jougasaki M, et al. Circulating natriuretic peptide concentrations in patients with end-stage renal disease: role of brain natfiuretic peptide as a biomarker for ventricular remodeling. Mayo Clin Proc, 2001,76:1111-1119.
  • 8Takami Y, Horio T, lwashima Y, et al. Diagnostic and prognostic value of plasma brain natriuretic peptide in nondialysis-dependent CRF. Am J Kidney Dis, 2004, 44:420-428.
  • 9Vickery S, Price CP, John RI, et al. B-type natriuretic peptide (BNP) and amino-terminal proBNP in patients with CKD: relationship to renal function and left ventricular hypertrophy. Am J Kidney Dis, 2005, 46:610-620.
  • 10Nakatani T, Naganuma T, Masuda C, et al. Significance of brain natriuretic peptides in patients on continuous ambulatory peritoneal dialysis. Int J Mol Med, 2002, 10:457-461.

共引文献40

同被引文献29

  • 1曲美他嗪Ⅳ期临床试验协作组.曲美他嗪治疗冠心病合并左心功能不全患者的疗效研究[J].中华心血管病杂志,2005,33(9):793-795. 被引量:123
  • 2徐静,何作云,冯兵,王建,陈卫,刘理,徐梓辉.曲美他嗪对肥大心肌细胞缺氧复氧的抗凋亡作用[J].重庆医学,2006,35(10):909-911. 被引量:5
  • 30’Meara F,MeMurray JJ.Myocardial metabolic manipulation:a newtherapeuticin heartfailure?[J].Heart,2005,9l(2):131-132.
  • 4RuizMeana M,Garcia D,Djulia M,et al.Ire-treatment with trimetazidine inere sarcolemmal mechanical resistance in n,Dxygenated myocytes[J].Cardiovasc Res,1996,3:578-591.
  • 5MauPoil V,Rochette L,Tabard A,et al.Evaluation of free radical formation during low-flow ischemia and reperfusion isolated rat heart[J].Cardiovas Drugs Ther,1990,4(Suppl 41):791-795.
  • 6Williams FM,Tanda K,Kus M,et al.Trimetazidine inhibits neutrophil accumulation after myocardial ischemia and reperfusion inrabbits[J].J Cardiovas pharmaeol,1993,22(6):828-833.
  • 7Marazzi G,Gebara O,Vitale C. Effect of trimetazidine on quality of life in elderly patients with ischemic dilated cardiomyopathy[J].{H}Advances in therapy,2009.455-461.
  • 8Roussel E,Gaudreau M,Plante E. Early responses of the left ventricle to pressure overload in Wistar rats[J].{H}Life Sciences,2008.265-272.
  • 9Hunt SA,Abraham WT,Chin MH. 2009 focused update incorporated into the ACC/AHA 2005 guidelines for the diagnosis and management of heart failure in adults[J].{H}Journal of the America College of Cardiology,2009.e1-e90.
  • 10Martos R,Baugh J,Ledwidge M. Diastolic heart failure:evidence of increased myocardial collagen turnover linked to diastolic dysfunction[J].{H}CIRCULATION,2007.888-895.

引证文献3

二级引证文献41

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部